Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Sources Sought opportunity from Department Of Health And Human Services was posted on March 2, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

ANNUAL MAINTENANCE/SERVICE ON TWO CYTEK AURORA FLOW CYTOMETRY SYSTEMS

Closed
NIAID-NOI-26-2278154Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

NAICS

811210 - Electronic and Precision Equipment Repair and Maintenance

Place of Performance

Rockville, MD, 20852, USA

Set-Aside

NONE

Documents

2
PDF, High priority: read this first3 pages · justification-and-authorization
High
PDF, Low priority2 pages · notice-of-intent
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

View Full Breakdown

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Niaid
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA

Full Description

Show more

This is a Notice of Intent (NOI). This notice is published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring the dissemination of information regarding proposed contract actions. This is a Notice of Intent to award a sole source, firm-fixed price purchase order under the authority of 41 U.S.C. 253 (c)(1), as implemented by FAR 13.106-1(b) and 13.501(a)- Only One Responsible Source and No Other Supplies or Service Will Satisfy Agency Requirements and is not a request for quotes. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Cytek Biosciences Inc.


Only one (1) award will be made as a result of this solicitation.  This will be awarded as a firm-fixed price type of contract.


Period of Performance(s) are as follows:


April 28, 2026 to April 27, 2027


Acquisition purpose and objectives:


The National Institutes of Health (NIH), National Institute of Allergy and Infectious Disease (NIAID), Laboratory of Immunoregulations (LIR) focuses its research efforts on the elucidation of cellular and molecular mechanisms of the regulation of the human immune response in health and disease. A major component of these research efforts involves high-dimensional immunophenotyping of lymphocytes isolated from the peripheral blood and lymphoid tissues of individuals enrolled in our HIV, SARS-CoV-2 and primary immunodeficiency clinical research protocols. To support its mission, the LIR purchased two Cytek Aurora cytometry systems over recent years. The machines are used by the LIR to immunophenotype cells isolated from peripheral blood and lymphoid tissues of participants in clinical research protocols clinical research protocols. This procurement is to co-term and continue service/maintenance for both LIR Aurora systems. 


While this synopsis does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy this requirement. The Government understands that Cytek Biosciences Inc is the only vendor who can provide required maintenance services for the laser equipment.


THIS IS NOT A SOLICITATION FOR COMPETITIVE QUOTATIONS.  All responsible sources that could provide the required services may submit a capability statement that will be considered by email (subject line to reference NIAID-NOI-26-2278154) to Linda Smith at Sign up to see this detail, by 11:00 am eastern standard time Monday, March 16, 2026.  All responses received by the closing date of this notice will be considered by the Government.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.


This notice does not obligate the Government to award a contract or otherwise pay for any information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Niaid

Same awarding agency

NAICS: 541715
Federal
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases
Solicitation # HHS-NIH-NIAID-BAA2026-1
The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals under Broad Agency Announcement HHS-NIH-NIAID-BAA2026-1 to advance medical interventions for infectious diseases. The initiative focuses on three primary research areas: the development of needle-free vaccine candidates through early phase clinical trials for viral pathogens; the creation of safe and effective therapeutic products for serious infectious diseases that are currently untreatable or drug-resistant; and the innovation of in vitro diagnostic technology platforms capable of rapid, point-of-care detection of priority viral families. For Fiscal Year 2027, NIAID estimates a total award amount of up to 16 million dollars for the non-severable base awards, with the potential for cost-reimbursement contracts lasting up to five years. Proposals must be submitted electronically via the eCPS portal by December 8, 2026, at 3:00 PM Eastern Time. Technical proposals are limited to 75 pages and will be evaluated by a peer review group based on scientific and technical merit, which is the paramount consideration for award. While cost is a factor, it is significantly less important than technical acceptability. Awardees will be required to adhere to Good Manufacturing Practice (GMP) for drug products and comply with HHS Section 508 accessibility standards. Key personnel must be named in the award, and a mandatory kick-off meeting is required within 60 days of the effective award date.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

10 days ago

DEADLINE

in 24 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS